BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 31585094)

  • 1. Oligodendrocyte Death in Pelizaeus-Merzbacher Disease Is Rescued by Iron Chelation.
    Nobuta H; Yang N; Ng YH; Marro SG; Sabeur K; Chavali M; Stockley JH; Killilea DW; Walter PB; Zhao C; Huie P; Goldman SA; Kriegstein AR; Franklin RJM; Rowitch DH; Wernig M
    Cell Stem Cell; 2019 Oct; 25(4):531-541.e6. PubMed ID: 31585094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of ER stress in dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 missense mutations shown by iPSC-derived oligodendrocytes.
    Numasawa-Kuroiwa Y; Okada Y; Shibata S; Kishi N; Akamatsu W; Shoji M; Nakanishi A; Oyama M; Osaka H; Inoue K; Takahashi K; Yamanaka S; Kosaki K; Takahashi T; Okano H
    Stem Cell Reports; 2014 May; 2(5):648-61. PubMed ID: 24936452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the Mutational and Phenotypic Landscapes of Pelizaeus-Merzbacher Disease with Human iPSC-Derived Oligodendrocytes.
    Nevin ZS; Factor DC; Karl RT; Douvaras P; Laukka J; Windrem MS; Goldman SA; Fossati V; Hobson GM; Tesar PJ
    Am J Hum Genet; 2017 Apr; 100(4):617-634. PubMed ID: 28366443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical Screening Identifies Enhancers of Mutant Oligodendrocyte Survival and Unmasks a Distinct Pathological Phase in Pelizaeus-Merzbacher Disease.
    Elitt MS; Shick HE; Madhavan M; Allan KC; Clayton BLL; Weng C; Miller TE; Factor DC; Barbar L; Nawash BS; Nevin ZS; Lager AM; Li Y; Jin F; Adams DJ; Tesar PJ
    Stem Cell Reports; 2018 Sep; 11(3):711-726. PubMed ID: 30146490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pelizaeus-Merzbacher disease: on the cusp of myelin medicine.
    Elitt MS; Tesar PJ
    Trends Mol Med; 2024 May; 30(5):459-470. PubMed ID: 38582621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of proteolipid protein rescues Pelizaeus-Merzbacher disease.
    Elitt MS; Barbar L; Shick HE; Powers BE; Maeno-Hikichi Y; Madhavan M; Allan KC; Nawash BS; Gevorgyan AS; Hung S; Nevin ZS; Olsen HE; Hitomi M; Schlatzer DM; Zhao HT; Swayze A; LePage DF; Jiang W; Conlon RA; Rigo F; Tesar PJ
    Nature; 2020 Sep; 585(7825):397-403. PubMed ID: 32610343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurogenetics of Pelizaeus-Merzbacher disease.
    Osório MJ; Goldman SA
    Handb Clin Neurol; 2018; 148():701-722. PubMed ID: 29478609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A common mechanism of PLP/DM20 misfolding causes cysteine-mediated endoplasmic reticulum retention in oligodendrocytes and Pelizaeus-Merzbacher disease.
    Dhaunchak AS; Nave KA
    Proc Natl Acad Sci U S A; 2007 Nov; 104(45):17813-8. PubMed ID: 17962415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene suppressing therapy for Pelizaeus-Merzbacher disease using artificial microRNA.
    Li H; Okada H; Suzuki S; Sakai K; Izumi H; Matsushima Y; Ichinohe N; Goto YI; Okada T; Inoue K
    JCI Insight; 2019 May; 4(10):. PubMed ID: 31092737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of the human induced pluripotent stem cell line (ZJUi005-A) from a patient with Pelizaeus-Merzbacher disease (PMD) carrying a novel hemizygous mutation in PLP1 gene.
    Liu B; Chen L; Sun J; Zhang L; Chen M; Qian Y; Wang Y; Yan K; Hou L; Huang Y; Zhang D; Xu Y; Yu J; Zhang J; Dong M
    Stem Cell Res; 2020 May; 45():101791. PubMed ID: 32402715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of curcumin in a mouse model of Pelizaeus-Merzbacher disease.
    Yu LH; Morimura T; Numata Y; Yamamoto R; Inoue N; Antalfy B; Goto Y; Deguchi K; Osaka H; Inoue K
    Mol Genet Metab; 2012 May; 106(1):108-14. PubMed ID: 22436581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of endoplasmic reticulum stress in Pelizaeus-Merzbacher disease by an anti-malaria drug, chloroquine.
    Morimura T; Numata Y; Nakamura S; Hirano E; Gotoh L; Goto YI; Urushitani M; Inoue K
    Exp Biol Med (Maywood); 2014 Apr; 239(4):489-501. PubMed ID: 24521562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural stem cells restore myelin in a demyelinating model of Pelizaeus-Merzbacher disease.
    Gruenenfelder FI; McLaughlin M; Griffiths IR; Garbern J; Thomson G; Kuzman P; Barrie JA; McCulloch ML; Penderis J; Stassart R; Nave KA; Edgar JM
    Brain; 2020 May; 143(5):1383-1399. PubMed ID: 32419025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant trafficking of a proteolipid protein in a mild Pelizaeus-Merzbacher disease.
    Koizume S; Takizawa S; Fujita K; Aida N; Yamashita S; Miyagi Y; Osaka H
    Neuroscience; 2006 Sep; 141(4):1861-9. PubMed ID: 16844304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the Innate Immune Response by Human Neural Precursors Prevails over Oligodendrocyte Progenitor Remyelination to Rescue a Severe Model of Pelizaeus-Merzbacher Disease.
    Marteyn A; Sarrazin N; Yan J; Bachelin C; Deboux C; Santin MD; Gressens P; Zujovic V; Baron-Van Evercooren A
    Stem Cells; 2016 Apr; 34(4):984-96. PubMed ID: 26676415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the natural history of Pelizaeus-Merzbacher disease.
    Mayer JA; Griffiths IR; Goldman JE; Smith CM; Cooksey E; Radcliff AB; Duncan ID
    Neurobiol Dis; 2015 Mar; 75():115-30. PubMed ID: 25562656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of Pelizaeus-Merzbacher disease (PMD) mutant (PLP1-C33Y) in induced pluripotent stem cell (iPSC) by CRISPR/Cas9 genome editing.
    Schreiber MK; Zafeiriou MP
    Stem Cell Res; 2024 Feb; 74():103276. PubMed ID: 38104430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced PLP1 expression in induced pluripotent stem cells derived from a Pelizaeus-Merzbacher disease patient with a partial PLP1 duplication.
    Shimojima K; Inoue T; Imai Y; Arai Y; Komoike Y; Sugawara M; Fujita T; Ideguchi H; Yasumoto S; Kanno H; Hirose S; Yamamoto T
    J Hum Genet; 2012 Sep; 57(9):580-6. PubMed ID: 22695888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concise Review: Stem Cell-Based Treatment of Pelizaeus-Merzbacher Disease.
    Osorio MJ; Rowitch DH; Tesar P; Wernig M; Windrem MS; Goldman SA
    Stem Cells; 2017 Feb; 35(2):311-315. PubMed ID: 27882623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease.
    Gow A; Southwood CM; Lazzarini RA
    J Cell Biol; 1998 Feb; 140(4):925-34. PubMed ID: 9472043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.